Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RAK Hospital delivers a broad range of secondary and tertiary care specialties, including innovations for prostate therapy (REZUM system), advanced cardiac/neuro/orthopedic surgery, a pioneering COVID-19 rehab program, and Bamlanivimab monoclonal antibody COVID-19 treatment. It is doubling bed capacity from 65 to 200 via partnership with CommonSpirit Health
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RAK Hospital.